Literature DB >> 30040606

Outcome factors in surgically treated patients for cervical spondylotic myelopathy.

Jiolanda Zika1, George A Alexiou2, Sotirios Giannopoulos3, Ioannis Kastanioudakis4, Athanasios P Kyritsis3, Spyridon Voulgaris2.   

Abstract

Context/Objective: To investigate prospectively preoperative parameters that might be related to the outcome of surgically treated patients for cervical spondylotic myelopathy (CSM).Design: Prospective study.Setting: Single Center in Ioannina, Greece.Participants: Thirty-six patients were included in the study. There were 21 males and 15 females, mean age 50.8 years, range 39-70 years. The mean BMI was 27.3.Outcome measures: From each patient, we recorded age, sex, BMI, symptoms, duration of symptoms, comorbidities, lifestyle, myelopathy grade based on MRI and levels of compression. All patients completed the modified JOA (mJOA) and NPE questionnaires preoperatively and at 1, 3, 12 months and 5-years postoperatively.
Results: The mean mJOA score significant improved from 10.8 ± 1.9 points preoperatively to 16.6 ± 2.2 points at 12 months postoperatively. The mean mJOA score at 5-years postoperatively was 15.5 ± 3 points. The difference was still highly significant. The mean NPE score significant improved from 59.8 ± 12.2 points preoperatively to 28.2 ± 8.5 points at 1 month, to 35.8 ± 8.1 points at 3 month and to 28.2 ± 8.8 points at 12 months postoperatively. Younger patients had significant higher baseline mJOA scores and significant higher mJOA scores 5-year postoperatively. No correlation was found between sex, BMI, symptom duration, baseline mJOA or myelopathy grade and outcome at 12 months or 5-year postoperatively.
Conclusion: Age was highly predictive factor of outcome for patients undergoing surgical treatment of CSM.

Entities:  

Keywords:  ACDF; Cervical spondylotic myelopathy; Surgery; outcome

Mesh:

Year:  2018        PMID: 30040606      PMCID: PMC7054977          DOI: 10.1080/10790268.2018.1500225

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  19 in total

Review 1.  Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis.

Authors:  Aria Nouri; Lindsay Tetreault; Anoushka Singh; Spyridon K Karadimas; Michael G Fehlings
Journal:  Spine (Phila Pa 1976)       Date:  2015-06-15       Impact factor: 3.468

Review 2.  Comparison of anterior approach versus posterior approach for the treatment of multilevel cervical spondylotic myelopathy.

Authors:  Jiaquan Luo; Kai Cao; Sheng Huang; Liangping Li; Ting Yu; Cong Cao; Rui Zhong; Ming Gong; Zhiyu Zhou; Xuenong Zou
Journal:  Eur Spine J       Date:  2015-04-04       Impact factor: 3.134

3.  The influence of body mass index on lumbar disc degeneration: comment on the article by Samartzis et al.

Authors:  George A Alexiou; Spyridon Voulgaris
Journal:  Arthritis Rheum       Date:  2012-12

Review 4.  Predictors of outcome in patients with degenerative cervical spondylotic myelopathy undergoing surgical treatment: results of a systematic review.

Authors:  Lindsay A Tetreault; Alina Karpova; Michael G Fehlings
Journal:  Eur Spine J       Date:  2013-02-06       Impact factor: 3.134

5.  Application value of diffusional kurtosis imaging (DKI) in evaluating microstructural changes in the spinal cord of patients with early cervical spondylotic myelopathy.

Authors:  Daowei Li; Xiaoming Wang
Journal:  Clin Neurol Neurosurg       Date:  2017-03-19       Impact factor: 1.876

6.  Cervical spondylotic myelopathy: pathophysiology, clinical presentation, and treatment.

Authors:  Darren R Lebl; Alex Hughes; Frank P Cammisa; Patrick F O'Leary
Journal:  HSS J       Date:  2011-06-22

7.  Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study.

Authors:  Michael G Fehlings; Jefferson R Wilson; Branko Kopjar; Sangwook Tim Yoon; Paul M Arnold; Eric M Massicotte; Alexander R Vaccaro; Darrel S Brodke; Christopher I Shaffrey; Justin S Smith; Eric J Woodard; Robert J Banco; Jens R Chapman; Michael E Janssen; Christopher M Bono; Rick C Sasso; Mark B Dekutoski; Ziya L Gokaslan
Journal:  J Bone Joint Surg Am       Date:  2013-09-18       Impact factor: 5.284

8.  Clinical prognostic indicators of surgical outcome in cervical spondylotic myelopathy.

Authors:  Langston T Holly; Paul G Matz; Paul A Anderson; Michael W Groff; Robert F Heary; Michael G Kaiser; Praveen V Mummaneni; Timothy C Ryken; Tanvir F Choudhri; Edward J Vresilovic; Daniel K Resnick
Journal:  J Neurosurg Spine       Date:  2009-08

9.  Diffusion tensor imaging of cervical spinal cord: A quantitative diagnostic tool in cervical spondylotic myelopathy.

Authors:  Zafer Orkun Toktas; Bahattin Tanrıkulu; Orkun Koban; Turker Kilic; Deniz Konya
Journal:  J Craniovertebr Junction Spine       Date:  2016 Jan-Mar

10.  Signal intensity ratio on magnetic resonance imaging as a prognostic factor in patients with cervical compressive myelopathy.

Authors:  Tae Hyun Kim; Yoon Ha; Jun Jae Shin; Yong Eun Cho; Ji Hae Lee; Woo Ho Cho
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

View more
  3 in total

1.  Effect of timeliness incentive nursing on postoperative rehabilitation in patients with cervical spondylotic myelopathy.

Authors:  Han'e Yue; Xianli Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Cacna2d2 inhibits axonal regeneration following surgical decompression in a rat model of cervical spondylotic myelopathy.

Authors:  Peisheng Liu; Xiaofeng Li; Jing Liu; Hengjia Zhang; Zhitao You; Jianfeng Zhang
Journal:  BMC Neurosci       Date:  2022-07-01       Impact factor: 3.264

3.  Perturbation-Based Balance Training in Postoperative Individuals With Degenerative Cervical Myelopathy.

Authors:  Yi-Shan Cheng; Andy Chien; Dar-Ming Lai; Ya-Yun Lee; Chih-Hsiu Cheng; Shwu-Fen Wang; Ya-Ju Chang; Jaw-Lin Wang; Wei-Li Hsu
Journal:  Front Bioeng Biotechnol       Date:  2020-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.